Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $252,079 | 37 | 92.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,900 | 7 | 3.6% |
| Food and Beverage | $5,763 | 295 | 2.1% |
| Travel and Lodging | $3,625 | 9 | 1.3% |
| Education | $39.96 | 3 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Rhodes Pharmaceuticals L.P. | $154,588 | 33 | $0 (2018) |
| ARBOR PHARMACEUTICALS, INC. | $97,572 | 9 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $13,398 | 77 | $0 (2024) |
| Shire North American Group Inc | $1,414 | 22 | $0 (2019) |
| Neos Therapeutics, LP | $657.22 | 18 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $352.41 | 20 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $350.94 | 14 | $0 (2024) |
| Tris Pharma Inc | $339.90 | 21 | $0 (2024) |
| Lundbeck LLC | $331.90 | 18 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $307.04 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $998.80 | 46 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($186.18) |
| 2023 | $845.57 | 45 | Supernus Pharmaceuticals, Inc. ($136.94) |
| 2022 | $1,235 | 74 | Supernus Pharmaceuticals, Inc. ($343.02) |
| 2021 | $13,148 | 50 | Supernus Pharmaceuticals, Inc. ($12,829) |
| 2020 | $194.68 | 10 | Allergan, Inc. ($48.79) |
| 2019 | $97,996 | 34 | ARBOR PHARMACEUTICALS, INC. ($97,551) |
| 2018 | $47,420 | 40 | Rhodes Pharmaceuticals L.P. ($45,840) |
| 2017 | $109,568 | 52 | Rhodes Pharmaceuticals L.P. ($108,748) |
All Payment Transactions
351 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.65 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: CNS | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.52 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.48 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Neuroscience | ||||||
| 10/16/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: ADHD | ||||||
| 09/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: ADHD | ||||||
| 08/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Neuropsychiatry | ||||||
| 08/14/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/07/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: ADHD | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.26 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/10/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/10/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/12/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| Category: ADHD | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Neuroscience | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RP-BP-EF003 | Rhodes Pharmaceuticals L.P. | $99,054 | 13 |
| Adult Attention Deficit Hyperactivity Disorder ADHD Study With Amphetamine Sulfate | Arbor Pharmaceuticals, Inc. | $97,535 | 7 |
| RP-BP-EF004 | Rhodes Pharmaceuticals L.P. | $55,491 | 17 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 43 | $4,730 | $2,456 |
| 2022 | 1 | 16 | 48 | $5,280 | $2,662 |
| 2021 | 1 | 16 | 49 | $5,390 | $3,271 |
| 2020 | 1 | 18 | 56 | $6,160 | $2,743 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 43 | $4,730 | $2,456 | 51.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 48 | $5,280 | $2,662 | 50.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 49 | $5,390 | $3,271 | 60.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 56 | $6,160 | $2,743 | 44.5% |
About Dr. Michael Greenbaum, MD
Dr. Michael Greenbaum, MD is a Psychiatry healthcare provider based in Libertyville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598792970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Greenbaum, MD has received a total of $271,406 in payments from pharmaceutical and medical device companies, with $998.80 received in 2024. These payments were reported across 351 transactions from 32 companies. The most common payment nature is "" ($252,079).
As a Medicare-enrolled provider, Greenbaum has provided services to 65 Medicare beneficiaries, totaling 196 services with total Medicare billing of $11,132. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Libertyville, IL
- Active Since 06/28/2006
- Last Updated 02/09/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598792970
Products in Payments
- Aptensio XR (Drug) $154,588
- AR19 (Drug) $97,535
- QELBREE (Drug) $10,268
- MYDAYIS (Drug) $1,239
- Adzenys XR-ODT (Drug) $642.79
- REXULTI (Drug) $523.21
- VRAYLAR (Drug) $314.14
- LATUDA (Drug) $295.07
- Dyanavel XR (Drug) $294.10
- JORNAY PM (Drug) $291.21
- CAPLYTA (Drug) $268.22
- HETLIOZ (Drug) $253.51
- VYVANSE (Drug) $206.13
- INGREZZA (Drug) $202.66
- SPRAVATO (Drug) $185.20
- Azstarys (Drug) $140.58
- Auvelity (Drug) $119.78
- SuperDimension (Device) $88.87
- Qelbree (Drug) $88.63
- ABILIFY MAINTENA (Drug) $69.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Libertyville
Dr. Paul Berkowitz, M.d, M.D
Psychiatry — Payments: $19,404
Dr. Elen Tylkin, M.d, M.D
Psychiatry — Payments: $5,748
Dr. Sandra Swain, M.d, M.D
Psychiatry — Payments: $329.54
Elisabeth Desapereira, Md, MD
Psychiatry — Payments: $193.55
Dr. Qurat Ul Ain Khan
Psychiatry — Payments: $23.08
Dr. Elvina Berman, M.d, M.D
Psychiatry